HC Wainwright & Co. Initiates Coverage On BioLife Solns with Buy Rating, Announces Price Target of $29
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has initiated coverage on BioLife Solutions (NASDAQ:BLFS) with a Buy rating and set a price target of $29.
September 30, 2024 | 10:39 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HC Wainwright & Co. has initiated coverage on BioLife Solutions with a Buy rating and a price target of $29, indicating a positive outlook for the stock.
The initiation of coverage with a Buy rating and a specific price target of $29 by HC Wainwright & Co. suggests a positive sentiment towards BioLife Solutions. This could lead to increased investor interest and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100